Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05672849 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases

A NA study of Neural Tube Defects, sponsored by Michael A Belfort.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05672849: Recruiting NA study of Neural Tube Defects, sponsored by Michael A Belfort.

NCT05672849 is a NA study of Neural Tube Defects that is actively recruiting participants, run by Michael A Belfort. The registered enrollment target is 100 participants, above the 43-participant average among 5 other Neural Tube Defects trials with a reported enrollment target (133% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05672849, a NA study of Neural Tube Defects, is actively recruiting participants, sponsored by Michael A Belfort.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate the safety and efficacy of devices used in patients undergoing fetoscopic neural tube defect repair.

Primary Outcome

Number of adverse events associated with the investigational device

Conditions Studied

Interventions

  • DEVICE Modified Surgical Instruments/Devices (Sheaths and Irrigator)

Study Locations (1)

Texas

  • Texas Childrens Hospital - Pavilion for Women - Houston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-11-14
Est. Completion 2027-12
Phase NA
Michael A Belfort

4 total trials

What NCT05672849 shows while recruiting

NCT05672849 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 43-participant average among 5 other Neural Tube Defects trials with a reported enrollment target (133% higher).

The record links to 1 condition, with Neural Tube Defects appearing as the primary indexed condition, and to 1 intervention - of which Modified Surgical Instruments/Devices (Sheaths and Irrigator) is the first listed.

NCT05672849 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05672849 about?

NCT05672849 is a clinical study titled "Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases". The purpose of the study is to evaluate the safety and efficacy of devices used in patients undergoing fetoscopic neural tube defect repair.

What is the current status of trial NCT05672849?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-11-14. Estimated completion is 2027-12.

What conditions does trial NCT05672849 study?

This clinical trial studies the following conditions: Neural Tube Defects.

What interventions are being tested in trial NCT05672849?

The interventions under investigation include: Modified Surgical Instruments/Devices (Sheaths and Irrigator) (DEVICE).

Who is sponsoring clinical trial NCT05672849?

This trial is sponsored by Michael A Belfort, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05672849 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neural Tube Defects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05672849, the US trial registry maintained by the National Library of Medicine. NCT05672849 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.